Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.57 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9285452 | 0.89 | BAZ2B (0.53) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL4544349 | 0.87 | BAZ2B (0.62) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL9154517 | 0.87 | BAZ2B (0.51) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL9147935 | 0.87 | BAZ2B (0.51) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL9151583 | 0.87 | BAZ2B (0.51) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL1004268 | 0.83 | ALDH1A1 (0.50) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL16364739 | 0.82 | BAZ2B (0.56) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL1149734 | 0.82 | ALDH1A1 (0.63) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL3113139 | 0.81 | BAZ2B (0.54) | BAZ2BBAZ2AALDH1A1GAAMEN1 | |
| SCHEMBL6899153 | 0.80 | DAO (0.60) | GAADAOL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4135842-B1 | PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | JANSSEN PHARMACEUTICA NV (BE) | 2024-10-23 | — | — | EP | disclosed |
| US-20230183248-A1 | PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | JANSSEN PHARMACEUTICA NV (BE) | 2023-06-15 | — | — | US | disclosed |
| US-20230183248-A1 | PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | JANSSEN PHARMACEUTICA NV (BE) | 2023-06-15 | — | — | US | disclosed |
| US-20230183248-A1 | PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | JANSSEN PHARMACEUTICA NV (BE) | 2023-06-15 | — | — | US | disclosed |
| EP-4135842-A1 | PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | JANSSEN Pharmaceutica NV (BE) | 2023-02-22 | — | — | EP | disclosed |
| CN-115485026-A | Pyrazolo [1,2-D ] [1,2,4] triazin-2-yl-acetamides as NLRP3 inflammatory pathway inhibitors | 詹森药业有限公司 | 2022-12-16 | — | — | CN | disclosed |
| WO-2021209539-A1 | PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | JANSSEN PHARMACEUTICA NV (BE) | 2021-10-21 | — | — | WO | disclosed |
| US-8197758-B2 | Bodipy fluorophore dyes useful in the labeling and identification of proteins; highly soluble | MONTANA STATE UNIVERSITY (US) | 2012-06-12 | — | — | US | disclosed |
| US-8197759-B2 | Bodipy fluorophore dyes useful in the labeling and identification of proteins; highly soluble | MONTANA STATE UNIVERSITY (US) | 2012-06-12 | — | — | US | disclosed |
| US-7833799-B2 | Zwitterionic dyes for labeling in proteomic and other biological analyses | MONTANA STATE UNIVERSITY (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100203645-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANAYLSES | NATIONAL SCIENCE FOUNDATION | 2010-08-12 | — | — | US | disclosed |
| US-20100036133-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | MONTANA STATE UNIVERSITY (US) | 2010-02-11 | — | — | US | disclosed |
| US-7582260-B2 | Zwitterionic dyes for labeling in proteomic and other biological analyses | MONTANA STATE UNIVERSITY (US) | 2009-09-01 | — | — | US | disclosed |
| US-20070259333-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | MONTANA STATE UNIVERSITY (US) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230183248-A1 | PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY | NLRP3, NLRP1, IL1B | BAZ2B 295/4885BAZ2A 256/4885ALDH1A1 898/4885 |
| US-20100203645-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANAYLSES | ACP1, ANXA5, CHAMP1 | BAZ2B 2261/4885BAZ2A 1814/4885ALDH1A1 2412/4885 |
| US-20100036133-A1 | NOVEL ZWITTERIONIC DYES FOR LABELING IN PROTEOMIC AND OTHER BIOLOGICAL ANALYSES | CHAMP1, ANXA5, ANXA3 | BAZ2B 2000/4885BAZ2A 2300/4885ALDH1A1 3530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.